Pathology Asia Holdings

News,Singapore,Investments,Asia,HealthTech

Mayo Clinic Laboratories invests in Pathology Asia and LifeStrands Genomics

Mayo Clinic Laboratories has invested in Singapore-based Pathology Asia Holdings and LifeStrands Genomics to expand advanced diagnostics and precision medicine across Asia Pacific.

September 23, 2026

NewsSingaporeInvestmentsAsiaHealthTech

Mayo Clinic Laboratories invests in Pathology Asia and LifeStrands Genomics

September 23, 2026

On Location

September 23, 2026

Global technology, AI trend help boost Southeast Asia’s growth: ADB

Mayo Clinic Laboratories invests in Pathology Asia and LifeStrands Genomics

September 23, 2026

Ofiniti to acquire ZeroNorth eBDN business as it expands in Singapore

September 23, 2026

Alibaba Cloud to open new regions in Europe, expand capacity in Malaysia and Hong Kong

September 23, 2026

Reap, Visa expand stablecoin-linked card programs to more than 100 markets

September 23, 2026

Major Player

October 28, 2021

Deploying modern enterprise services in the cloud

October 28, 2021

Grab wants to be the future of retail

June 9, 2020

Traditional retailers need digital transformation to keep up with consumers

September 20, 2018

Cross Border

September 23, 2026

Global technology, AI trend help boost Southeast Asia’s growth: ADB

Mayo Clinic Laboratories invests in Pathology Asia and LifeStrands Genomics

September 23, 2026

Ofiniti to acquire ZeroNorth eBDN business as it expands in Singapore

September 23, 2026

Alibaba Cloud to open new regions in Europe, expand capacity in Malaysia and Hong Kong

September 23, 2026

Reap, Visa expand stablecoin-linked card programs to more than 100 markets

September 23, 2026